Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-02-14

Clinical Trial Update: Oral Ivermectin for Chikungunya Viral Infection [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating oral ivermectin for chikungunya viral infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IVERMECTIN (Ivermectin)

Snippet

Sponsor: Prince of Songkla University | Conditions: Clinical Syndrome | Phase 3 | Status: COMPLETED